196 related articles for article (PubMed ID: 26338038)
21. Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies.
López-Isac E; Martín JE; Assassi S; Simeón CP; Carreira P; Ortego-Centeno N; Freire M; Beltrán E; Narváez J; Alegre-Sancho JJ; ; Fernández-Gutiérrez B; Balsa A; Ortiz AM; González-Gay MA; Beretta L; Santaniello A; Bellocchi C; Lunardi C; Moroncini G; Gabrielli A; Witte T; Hunzelmann N; Distler JH; Riekemasten G; van der Helm-van Mil AH; de Vries-Bouwstra J; Magro-Checa C; Voskuyl AE; Vonk MC; Molberg Ø; Merriman T; Hesselstrand R; Nordin A; Padyukov L; Herrick A; Eyre S; Koeleman BP; Denton CP; Fonseca C; Radstake TR; Worthington J; Mayes MD; Martín J
Arthritis Rheumatol; 2016 Sep; 68(9):2338-44. PubMed ID: 27111665
[TBL] [Abstract][Full Text] [Related]
22. Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population.
Dieudé P; Guedj M; Wipff J; Ruiz B; Riemekasten G; Matucci-Cerinic M; Melchers I; Hachulla E; Airo P; Diot E; Hunzelmann N; Cabane J; Mouthon L; Cracowski JL; Riccieri V; Distler J; Meyer O; Kahan A; Boileau C; Allanore Y
Ann Rheum Dis; 2010 Nov; 69(11):1958-64. PubMed ID: 20511617
[TBL] [Abstract][Full Text] [Related]
23. A GWAS follow-up study reveals the association of the IL12RB2 gene with systemic sclerosis in Caucasian populations.
Bossini-Castillo L; Martin JE; Broen J; Gorlova O; Simeón CP; Beretta L; Vonk MC; Callejas JL; Castellví I; Carreira P; García-Hernández FJ; Fernández Castro M; ; Coenen MJ; Riemekasten G; Witte T; Hunzelmann N; Kreuter A; Distler JH; Koeleman BP; Voskuyl AE; Schuerwegh AJ; Palm Ø; Hesselstrand R; Nordin A; Airó P; Lunardi C; Scorza R; Shiels P; van Laar JM; Herrick A; Worthington J; Denton C; Tan FK; Arnett FC; Agarwal SK; Assassi S; Fonseca C; Mayes MD; Radstake TR; Martin J
Hum Mol Genet; 2012 Feb; 21(4):926-33. PubMed ID: 22076442
[TBL] [Abstract][Full Text] [Related]
24. Association of polymorphisms across the tyrosine kinase gene, TYK2 in UK SLE families.
Cunninghame Graham DS; Akil M; Vyse TJ
Rheumatology (Oxford); 2007 Jun; 46(6):927-30. PubMed ID: 17384181
[TBL] [Abstract][Full Text] [Related]
25. A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility.
López-Isac E; Bossini-Castillo L; Simeon CP; Egurbide MV; Alegre-Sancho JJ; Callejas JL; Roman-Ivorra JA; Freire M; Beretta L; Santaniello A; Airó P; Lunardi C; Hunzelmann N; Riemekasten G; Witte T; Kreuter A; Distler JH; Schuerwegh AJ; Vonk MC; Voskuyl AE; Shiels PG; van Laar JM; Fonseca C; Denton C; Herrick A; Worthington J; Assassi S; Koeleman BP; Mayes MD; Radstake TR; Martin J;
Arthritis Res Ther; 2014 Jan; 16(1):R6. PubMed ID: 24401602
[TBL] [Abstract][Full Text] [Related]
26. Association between the -174 C/G polymorphism in the interleukin-6 (IL-6) gene and gastrointestinal involvement in patients with systemic sclerosis.
Zekovic A; Vreca M; Spasovski V; Andjelkovic M; Pavlovic S; Damjanov N
Clin Rheumatol; 2018 Sep; 37(9):2447-2454. PubMed ID: 29948346
[TBL] [Abstract][Full Text] [Related]
27. Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis.
Allanore Y; Saad M; Dieudé P; Avouac J; Distler JH; Amouyel P; Matucci-Cerinic M; Riemekasten G; Airo P; Melchers I; Hachulla E; Cusi D; Wichmann HE; Wipff J; Lambert JC; Hunzelmann N; Tiev K; Caramaschi P; Diot E; Kowal-Bielecka O; Valentini G; Mouthon L; Czirják L; Damjanov N; Salvi E; Conti C; Müller M; Müller-Ladner U; Riccieri V; Ruiz B; Cracowski JL; Letenneur L; Dupuy AM; Meyer O; Kahan A; Munnich A; Boileau C; Martinez M
PLoS Genet; 2011 Jul; 7(7):e1002091. PubMed ID: 21750679
[TBL] [Abstract][Full Text] [Related]
28. Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor.
Ban M; Goris A; Lorentzen AR; Baker A; Mihalova T; Ingram G; Booth DR; Heard RN; Stewart GJ; Bogaert E; Dubois B; Harbo HF; Celius EG; Spurkland A; Strange R; Hawkins C; Robertson NP; Dudbridge F; Wason J; De Jager PL; Hafler D; Rioux JD; Ivinson AJ; McCauley JL; Pericak-Vance M; Oksenberg JR; Hauser SL; Sexton D; Haines J; Sawcer S; ; Compston A
Eur J Hum Genet; 2009 Oct; 17(10):1309-13. PubMed ID: 19293837
[TBL] [Abstract][Full Text] [Related]
29. Th17 pathway genes polymorphisms in Algerian patients with systemic sclerosis.
Mellal Y; Allam I; Tahiat A; Abessemed A; Nebbab R; Ladjouze A; Djidjik R
Acta Reumatol Port; 2018; 43(4):269-278. PubMed ID: 30641535
[TBL] [Abstract][Full Text] [Related]
30. IL-1A rs1800587, IL-1B rs1143634 and IL-1R1 rs2234650 polymorphisms in Iranian patients with systemic sclerosis.
Abtahi S; Farazmand A; Mahmoudi M; Ashraf-Ganjouei A; Javinani A; Nazari B; Kavosi H; Amirzargar AA; Jamshidi AR; Gharibdoost F
Int J Immunogenet; 2015 Dec; 42(6):423-7. PubMed ID: 26416393
[TBL] [Abstract][Full Text] [Related]
31. The interleukin 23 receptor gene does not confer risk to systemic sclerosis and is not associated with systemic sclerosis disease phenotype.
Rueda B; Broen J; Torres O; Simeon C; Ortego-Centeno N; Schrijvenaars MM; Vonk MC; Fonollosa V; van den Hoogen FH; Coenen MJ; Sanchez-Román J; Aguirre-Zamorano MA; García-Portales R; Pros A; Camps MT; Gonzalez-Gay MA; Martin J; Radstake TR
Ann Rheum Dis; 2009 Feb; 68(2):253-6. PubMed ID: 18713787
[TBL] [Abstract][Full Text] [Related]
32. The IL-33 gene is related to increased susceptibility to systemic sclerosis.
Koca SS; Pehlivan Y; Kara M; Alibaz-Oner F; Oztuzcu S; Yilmaz N; Cetin GY; Kisacik B; Ozgen M; Pamuk ON; Direskeneli H; Sayarlioglu M; Onat AM
Rheumatol Int; 2016 Apr; 36(4):579-84. PubMed ID: 26743213
[TBL] [Abstract][Full Text] [Related]
33. Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis.
Arismendi M; Giraud M; Ruzehaji N; Dieudé P; Koumakis E; Ruiz B; Airo P; Cusi D; Matucci-Cerinic M; Salvi E; Cuomo G; Hachulla E; Diot E; Caramaschi P; Riccieri V; Avouac J; Kayser C; Allanore Y
Arthritis Res Ther; 2015 Mar; 17(1):71. PubMed ID: 25880423
[TBL] [Abstract][Full Text] [Related]
34. FOXP3, ICOS and ICOSL gene polymorphisms in systemic sclerosis: FOXP3 rs2294020 is associated with disease progression in a female Italian population.
D'Amico F; Fiorito G; Skarmoutsou E; Granata M; Rossi GA; Trovato C; Bellocchi C; Marchini M; Beretta L; Mazzarino MC
Immunobiology; 2018 Jan; 223(1):112-117. PubMed ID: 29030005
[TBL] [Abstract][Full Text] [Related]
35. No evidence of association between functional polymorphisms located within IL6R and IL6ST genes and systemic sclerosis.
Cénit MC; Simeón CP; Fonollosa V; Espinosa G; Beltrán E; Sáez-Comet L; Vicente-Rabaneda E; García-Hernández FJ; Martínez-Estupiñán L; Rodríguez-Carballeira M; Hernández V; de la Peña PG; Fernández-Castro M; Narváez FJ; Pros A; Gallego M; Ríos-Fernández R; Camps MT; Fernández-Nebro A; Egurbide MV; Carreira P; González-Gay MA; Martín J;
Tissue Antigens; 2012 Sep; 80(3):254-8. PubMed ID: 22742541
[TBL] [Abstract][Full Text] [Related]
36. Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility.
Couturier N; Bucciarelli F; Nurtdinov RN; Debouverie M; Lebrun-Frenay C; Defer G; Moreau T; Confavreux C; Vukusic S; Cournu-Rebeix I; Goertsches RH; Zettl UK; Comabella M; Montalban X; Rieckmann P; Weber F; Müller-Myhsok B; Edan G; Fontaine B; Mars LT; Saoudi A; Oksenberg JR; Clanet M; Liblau RS; Brassat D
Brain; 2011 Mar; 134(Pt 3):693-703. PubMed ID: 21354972
[TBL] [Abstract][Full Text] [Related]
37. Brief report: candidate gene study in systemic sclerosis identifies a rare and functional variant of the TNFAIP3 locus as a risk factor for polyautoimmunity.
Koumakis E; Giraud M; Dieudé P; Cohignac V; Cuomo G; Airò P; Hachulla E; Matucci-Cerinic M; Diot E; Caramaschi P; Mouthon L; Riccieri V; Cracowski JL; Tiev KP; Francès C; Amoura Z; Sibilia J; Cosnes A; Carpentier P; Valentini G; Manetti M; Guiducci S; Meyer O; Kahan A; Boileau C; Chiocchia G; Allanore Y
Arthritis Rheum; 2012 Aug; 64(8):2746-52. PubMed ID: 22488580
[TBL] [Abstract][Full Text] [Related]
38. Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis.
Hutyrová B; Lukác J; Bosák V; Buc M; du Bois R; Petrek M
J Rheumatol; 2004 Jan; 31(1):81-4. PubMed ID: 14705223
[TBL] [Abstract][Full Text] [Related]
39. The autoimmune disease-associated IL2RA locus is involved in the clinical manifestations of systemic sclerosis.
Martin JE; Carmona FD; Broen JC; Simeón CP; Vonk MC; Carreira P; Ríos-Fernández R; Espinosa G; Vicente-Rabaneda E; Tolosa C; García-Hernández FJ; Castellví I; Fonollosa V; González-Gay MA; Sáez-Comet L; Portales RG; de la Peña PG; Fernández-Castro M; Díaz B; Martínez-Estupiñán L; Coenen M; Voskuyl AE; Schuerwegh AJ; Vanthuyne M; Houssiau F; Smith V; de Keyser F; De Langhe E; Riemekasten G; Witte T; Hunzelmann N; Kreuter A; Palm Ø; Chee MM; van Laar JM; Denton C; Herrick A; Worthington J; Koeleman BP; Radstake TR; Fonseca C; Martín J;
Genes Immun; 2012 Feb; 13(2):191-6. PubMed ID: 22012429
[TBL] [Abstract][Full Text] [Related]
40. Confirmation of TNIP1 but not RHOB and PSORS1C1 as systemic sclerosis risk factors in a large independent replication study.
Bossini-Castillo L; Martin JE; Broen J; Simeon CP; Beretta L; Gorlova OY; Vonk MC; Ortego-Centeno N; Espinosa G; Carreira P; García de la Peña P; Oreiro N; Román-Ivorra JA; Castillo MJ; González-Gay MA; Sáez-Comet L; Castellví I; Schuerwegh AJ; Voskuyl AE; Hoffmann-Vold AM; Hesselstrand R; Nordin A; Lunardi C; Scorza R; van Laar JM; Shiels PG; Herrick A; Worthington J; Fonseca C; Denton C; Tan FK; Arnett FC; Assassi S; Koeleman BP; Mayes MD; Radstake TR; Martin J;
Ann Rheum Dis; 2013 Apr; 72(4):602-7. PubMed ID: 22896740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
